Xarelto is a blood thinner which is manufactured by Bayer and is marketed by Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals. The drug is use by millions of people for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and for extended risk reduction. Although Xarelto has been promoted as safe and effective drug it is associated with several dangerous adverse events including, brain hemorrhaging, rectal bleeding, intestinal bleeding, blood clots, pulmonary embolism, and deep vein thrombosis. One of the most severe side effects of Xarelto is uncontrolled bleeding. Unlike warfarin, there is no known antidote to stop bleeding caused by this medication leading many doctors to hold off on prescribing the drugs. Despite all these complications and risk of no antidote the drug is one of the top selling medicines in the market.
Recently a study was done by the researchers of Mayo Clinic who examined the effects of the three anticoagulants on roughly 57,000 patients suffering from non-valve atrial fibrillation and pulmonary embolism (PE). The drug includes Xarelto, Eliquis, and Pradaxa. As per the study Xarelto was associated with more incidents of gastrointestinal bleeding than the other two. Xarelto have received two ‘black box’ warnings from the FDA. These warnings are the strictest warning a product can receive before being pulled completely from the market. Many studies reveals that the patient who takes Xarelto had a 15 percent higher chance of death, 65 percent higher chance of brain bleeds and 48 percent increased risk of major brain bleeds. Johnson & Johnson and Janssen Pharmaceuticals are recklessly promoting the drug as safe despite warn doctors and patient about the risk and complications cause by the drug due to the lack of its reversal agent.
In a recent lawsuit filed against Xarelto manufacturers the plaintiff suffered from atrial fibrillation. Xarelto was prescribed to the plaintiff to help prevent any chance of a stroke happening. After only 5 months of taking Xarelto, the plaintiff claims that she began experiencing difficulties resulting from an uncontrollable internal bleeding event. The lawsuit alleges Bayer and Janssen Pharmaceuticals failed to adequately warn doctors as well as patients about the adverse effects cause by the life threatening drug Xarelto and the manufacturers were reckless in releasing the drug to market without a corresponding antidote, which can lead Xarelto to cause someone to bleed to death. The drug makers may have reduced the risk of patients dying on Xarelto from uncontrollable bleeding if they had provided stronger warnings and recommended blood monitoring during treatment as a result thousands of lawsuit have been filed.
The lawsuits against Xarelto have now reached 15,000 across the country. The FDA decision to say Xarelto a safe and effective drug will not likely to stop additional Xarelto adverse effects lawsuits. If you or your love ones are facing fatal complication or serious bleeding event after taking Xarelto can take a legal action against the company. He/she can claim for reimbursement money against complication or any loss. We have an experience attorneys group who Investigating Lawsuits over Xarelto Bleeding Problems. We evaluate your case free of cost unless we win the case for you. Contact Drugsclaim.com for free and confidential case review.